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Abstract
Background/Objectives
To examine associations of different anthropometric measurements of central adiposity to
visceral adipose tissue (measured via multi-axial magnetic resonance imaging; MRI) and
cardiometabolic disease risk factors in men with spinal cord injury (SCI). Additionally, to
determine population-specific seated/supine waist and abdominal circumference cutoffs,
which may identify men at increased risk of cardiometabolic disease.
Participants/Methods
Twenty-two men with chronic SCI underwent MRI scans, anthropometric measurements
along with assessments of various cardiometabolic risk biomarkers. Pearson/part (account-
ing for age as a covariate) correlation coefficients were calculated to determine the associa-
tions between study variables. Abdominal and waist circumference cutoffs were
extrapolated using the slope of linear regression equations.
Results
Seated/supine abdominal and waist circumferences were (P < 0.01) associated with MRI
visceral fat cross-sectional area (VATCSA), VAT volume and CSA:TotalCSA. Low density
lipoprotein, non-high-density lipoprotein and total cholesterol were positively associated
with seated/supine abdominal and waist circumferences after controlling for age; r = 0.50–
0.61, r = 0.46–0.58, r = 0.52–0.58, P < 0.05, respectively. Tumor necrosis factor alpha was
associated with seated/supine abdominal and waist circumferences after accounting for
age; r = 0.49–0.51 and r = 0.48–0.56, P < 0.05 respectively. The population-specific cutoffs
were 86.5cm and 88.3cm for supine waist and abdominal circumferences, respectively, as
well as 89cm and 101cm for seated waist and abdominal circumferences, respectively.
After dichotomizing VATCSA (< or 100cm2), peak oxygen uptake, triglycerides, insulin sen-
sitivity and glycated hemoglobin were different (P < 0.05) between groups. After dichotomiz-
ing (< or 86.5cm) supine waist circumference, VATCSA, triglycerides and insulin sensitivity
were different (P < 0.05) between groups.
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Conclusions
Seated/supine circumferences are associated with both central adiposity and biomarkers of
cardiometabolic disease risk in persons with SCI. Population-specific cutoffs are proposed
herein to identify central adiposity and potential cardiometabolic disease risk after SCI.
Introduction
Obesity is rapidly becoming a serious problem in persons that have physical disabilities, with a
1.2 to 3.9-fold increase in prevalence compared to the general population [1]. Specifically, in
persons with spinal cord injury (SCI), the best data available would suggest that two in every
three persons with SCI are likely to be obese [2]. The mechanisms by which obesity occurs in
persons with SCI are multifactorial and these physiological processes have been eloquently
described previously by the conceptual model of Disability-Associated Low Energy Expendi-
ture Deconditioning Syndrome [3]. Following SCI, significant atrophy of paralyzed skeletal
muscle and mobility impairments lead to a reduction in basal metabolic rate (BMR) and physi-
cal activity energy expenditure (PAEE), respectively [4,5]. Alterations in these key components
of energy expenditure contributes to an energy surplus, which if maintained, favors the devel-
opment of obesity. It has also been suggested that social factors (e.g. comfort food provided by
family/friends), functional challenges (e.g. problems encountered when preparing food), phys-
ical barriers (e.g. transport to shops and supermarket store shelving) and environment (e.g.
hospital food) also contribute to an ‘obesogenic environment’ in this population [6]. Obesity
has been addressed as one of the key modifiable risk factors for the development of type II dia-
betes mellitus and cardiovascular disease (CVD) in persons with SCI [7] and, likely drives the
increased prevalence of these chronic diseases compared to able-bodied individuals [8].
The accumulation of adipose tissue in different depots is altered in persons with SCI. In
comparison to able-bodied controls, visceral adipose tissue (VAT) quantified by single slice
computed tomography (CT) at the umbilical and L4-L5 levels have been shown to be 34% [9]
and 45% (58% after adjusting for weight differences) [10] greater in persons with SCI.
VATCSA, measured by single-slice CT scan, has shown to be positively correlated with homeo-
stasis model assessment of insulin resistance (HOMA-IR) and fasting insulin concentrations
in persons with SCI [9, 10]. Gorgey et al, [11], demonstrated that VAT cross-sectional area
(VATCSA) quantified across multi-axial slices compared to a single-axial CSA is adequately
describing the true associations between central adiposity and metabolic profile. These authors
also demonstrated that VATCSA was positively and negatively associated with fasting plasma
glucose (FPG) and insulin concentrations, respectively, but not post-load indices of insulin
resistance measured during an oral glucose tolerance test. As FPG concentrations have been
shown to correlate with basal rates of hepatic glucose output [12] and HOMA-IR predomi-
nantly reflects hepatic insulin sensitivity [13], the associations between VAT and peripheral
insulin resistance in persons with SCI remains to be assessed using a more sensitive measure
of skeletal muscle/adipose tissue insulin sensitivity (i.e. intravenous glucose tolerance test;
IVGTT).
While previous research in this population has used gold-standard VAT imaging tech-
niques (i.e. MRI and CT), barriers such as the high cost, accessibility to scanner and require-
ment for trained personnel often limit the sample size of such research studies and the
feasibility of use in clinical settings. Although body mass index (BMI) is the most commonly
used measure of obesity in the SCI literature [14], it is not an appropriate tool to use with this
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population given the deleterious body composition changes that occur post injury [4]. In the
general population, waist and hip circumferences have been used as surrogate measures for
central (i.e. VAT) and gluteofemoral (i.e. SAT) adiposity. The National Cholesterol Education
Program report (NCEP) defined waist circumference cutoffs for obesity> 102cm, based on
epidemiological evidence using able-bodied men [15]. However, these standard cutoffs may
not be appropriate for persons with SCI. In Japanese men with SCI, supine waist
circumference 81.3cm has been suggested to correspond to a VATCSA 100cm
2 [16]. More-
over, in males and females with SCI, supine waist circumference 94cm has been proposed as
the optimal cutoff for identifying increased CVD risk in this population specifically [17].
Despite waist circumferences being correlated to a range of cardiometabolic disease risk bio-
markers [18] and its ease of use in multiple settings, there remains ambiguity as to which posi-
tion (supine vs. seated) and cutoff best represents central adiposity and adverse CVD risk
profiles in persons with SCI. Conflicting information regarding obesity in persons with SCI is
due to, in part, the inconsistent use of obesity measurement tools or classification cutoffs that
have not been validated for use in this population. Therefore, the purpose of this study is to
identify the associations between: (i) seated/supine anthropometric measurements of central
adiposity and VATCSA (quantified by the gold-standard multi-axial slice MRI); (ii) seated/
supine anthropometric measurements of central adiposity and a range of biomarkers of cardi-
ometabolic disease and, (iii) propose new population specific cutoffs for both seated/supine
anthropometrics. This study aimed to identify the most adequate anthropometric measure-
ment that is likely to detect both central obesity and elevated CVD risk in persons with SCI,
while also proposing suitable population specific obesity cutoffs.
Materials and methods
Participants
Twenty-two men, aged between 18–50 years old, BMI 30kg/m2, with chronic motor com-
plete SCI (C5-T11; American Spinal Cord Injury Classification A or B) participated in the
TEREX-SCI trial (registered at clinicaltrials.gov: NCT01652040) [19]. Only cross-sectional
baseline data is presented in this manuscript. The McGuire Veteran Affairs Investigation
Research Board and the Virginia Commonwealth University (VCU) Office of Research and
Innovation approved the current study. A neurological examination was performed per the
International Standards for Neurological Classification of SCI (ISNCSCI) to determine the
American Spinal Injury Association (ASIA) Impairment Scale (AIS) for each participant. Par-
ticipants provided written, informed consent before the study commenced. Participants with
the following pre-existing medical conditions were excluded: active urinary tract infection,
stage 2 pressure ulcer, cardiovascular disease and/or uncontrolled type II diabetes mellitus.
Anthropometric measurements
Participants were instructed to void their bladder before undergoing anthropometric measure-
ments. Height was measured to the nearest 0.1cm by placing a wooden transfer board at the
soles of the feet to ensure neutral dorsiflexion using a Harpenden Stadiometer while in a
supine position. To establish each participants weight, the weight of the wheelchair was sub-
tracted from the weight of the participant and wheelchair measured using a wheelchair weigh-
ing scale (Tanita, PW-63OU). Both waist and abdominal circumferences were measured in
sitting and supine positions using a standard inflexible measuring tape (MFG, Lufkin, Execu-
tive Diameter Pocket Tape measure). Waist circumference was taken at the midpoint between
the crest of the ilium and the inferior margin of the last rib. Abdominal circumference was
measured at the level of the umbilicus. Supine hip circumference was also measured around
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the widest part of the trochanters. All measurements were made after the exhalation of a pre-
ceding deep breath. Values were recorded to the nearest 0.1cm and the mean of three values
(within 0.5cm of each other) calculated. Supine waist circumference was divided by hip cir-
cumference to derive a waist-to-hip ratio for each participant. These anthropometric locations
were chosen as they are commonly used in the wider SCI body composition literature [10, 20,
21, 22].
Magnetic Resonance Imaging (MRI)
Abdominal MRI images were captured using a 1.5-Tesla magnet (General Electric, Waukesha,
WI) whole body scanner, using a fast spin-echo sequence described previously [23]. Trans-
verse images with a slice thickness of 0.8cm and inter-slice space of 1.2cm were captured from
the xiphoid process to the femoral heads. Approximately 20–30 images were obtained depend-
ing on the length of the participant’s torso. Participants were instructed to remain as still as
possible during the scan. To prevent any respiratory artefacts that could alter the quality of the
images, participants were also asked to hold their breath for approximately 20 seconds. Images
were sequenced anatomically using Image-J software (National Institute of Health, Bethesda,
Maryland) and analyzed using specifically designed software (Win Vessel 2.0, Ronald Meyer,
MSU). Each image was automatically segmented into fat and muscle, with bone and back-
ground tissue identified based on its signal intensity. Abdominal adipose tissue was separated
into SAT and VAT (intraperitoneal and retroperitoneal fat) depots by an experienced techni-
cian, who manually highlighted regions of interest guided by anatomical landmarks. The
cross-sectional areas (CSA’s) of these different compartments were used to derive VAT:SAT
ratio. Total trunk CSA was defined as the total area within the outer border of the trunk. These
data were used to normalize VATCSA to TotalCSA (VAT:Total ratio). All values were averaged
across images to reflect the whole torso. VAT volume (cm3) was calculated by multiplying the
CSA by the slice thickness (0.8cm) and inter-slice space (1.2cm).
Indirect calorimetry and assessment of cardiometabolic disease risk
biomarkers
Participants were woken up ~6.30 am, following a 12 hour overnight fast during an inpatient
stay at a local hospital. Basal metabolic rate (BMR) was measured via indirect calorimetry
using a portable metabolic system (COSMED K4b2, Rome, Italy) in a darkened, thermoneutral
environment (ambient temperature between 20–25˚C). The unit was calibrated prior to use
per manufacturer’s instructions. Following calibration, a canopy was placed over the partici-
pant’s head as they lay in a supine position, with continuous breath-by-breath measurements
made over a 20-minute period. Gas exchange values for the first five minutes were discarded,
with BMR (kcal/day) averaged over the last 15 minutes. Following the measurement of BMR a
cannula was inserted into an antecubital vein. Fasting whole-blood samples were drawn into
serum separator and potassium oxalate/sodium fluoride tubes and centrifuged to collect
serum and plasma samples, respectively. Lipid profiles (serum high-density lipoprotein choles-
terol; HDL-C, Low-density lipoprotein cholesterol; LDL-C, Total cholesterol and triglycerides;
TG) and plasma free-fatty acids (FFAs) were analyzed using enzymatic colorimetric quantifi-
cation. Inflammatory biomarkers (Tumor necrosis factor α; TNF-α, Interleukin-6; IL-6 and c-
reactive protein; CRP) were also analyzed in serum samples by enzyme-linked immunosorbent
assays (ELISA) (ALPACO; Salem, NH).
Another cannula was inserted into the opposite arm to facilitate an intravenous glucose tol-
erance test (IVGTT), whereby participants were administered glucose (0.3g/kg intravenously
over 30 seconds) followed by a bolus of insulin (0.02U/kg) twenty minutes later. Blood samples
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were drawn from the opposite arm every 1–3 minutes for the first 30 minutes, 5–10 minutes
for the next 40 minutes and every 20 minutes for the next 80 minutes. The intravenous cannula
was kept patent through periodic flushing with 0.9% NaCI. Plasma insulin and glucose were
measured by ELISA (ALPACO; Salem, NH) and using a biochemistry analyzer, respectively.
Glucose effectiveness (Sg) and insulin sensitivity (Si) were determined using the MinMod soft-
ware (MinMod Inc., Pasadena, CA) as described previously [24] (Diabetes Technology and
Therapeutics). Glycated hemoglobin (HbA1c) was measured using a standard procedure in
the VCU pathology laboratory. Peak lower extremity oxygen uptake (VO2 peak) was assessed
in a subsample of participants (n = 15) at the point of fatigue on a FES bike (Restorative Thera-
pies, RTI-300) during an incremental exercise protocol whereby the bike resistance was manu-
ally increased every 2 minutes (1, 3, 5, 7 Nm) until fatigue, defined by dropping the cycling
rate to 18 revolutions per minute [25, 26]. Electrical stimulation electrodes were applied bilat-
erally to the quadriceps, hamstrings and gluteal muscles to facilitate cycling of the paralyzed
lower extremities.
Statistical analysis
All data were analyzed for normality of distribution. The distributions of TG, CRP, TNF-α, Si
and Sg were positively skewed. Thus, these data were log-transformed to permit the use of
parametric statistics. IL-6 was negatively skewed and therefore reflected prior to log-transfor-
mation. Age, time since injury, level of injury, height, and weight were assessed as covariates
through bivariate correlations with MRI outcomes, anthropometric measurements of central
adiposity and biomarkers of cardiometabolic disease. Linear regression models were used to
examine the relationship between the measures of central adiposity (MRI outcomes and
anthropometric measurements) and biomarkers of cardiometabolic disease. From this, Pear-
son correlation coefficients (r) and part correlations, accounting for age, were chosen to assess
the associations between MRI outcomes, anthropometric measurements of central adiposity
and biomarkers of cardiometabolic disease. The following descriptors were used to help inter-
pret the magnitude of each correlation: small (r> 0.1), moderate (r> 0.3), large (r> 0.5) and,
very large (r> 0.7) [27, 28]. Where significant correlations were observed for VATCSA with
biomarkers of cardiometabolic disease, participants were dichotomized into two groups using
accepted cut-points for abdominal obesity; < 100cm2 (n = 11) or 100cm2 (n = 11) [11].
Seated and supine abdominal and waist circumference cutoffs, equivalent to 100cm2 VATCSA,
were calculated using linear regression equations to derive population-specific waist circum-
ference cutoffs. Participants were also dichotomized based on supine and seated anthropo-
metrics to examine the effects on VAT and various biomarkers of cardiometabolic disease
using the newly developed cutoffs. Two-tailed independent T-Tests were used to determine
significant differences between groups for parameters of central adiposity and various bio-
markers of cardiometabolic disease. Statistical analyses were performed using SPSS (SPSS Sta-
tistics version 24, IBM Corp, Armonk, USA). Statistical significance was accepted at a priori of
α 0.05.
Results
Participant demographics, injury characteristics, anthropometric measurements, MRI out-
comes and biomarkers of cardiometabolic disease are presented in Table 1. Fifty-nine percent
of participants had depressed HDL-C (< 35mg/dL), whereas only 9% of participants had ele-
vated levels of total cholesterol ( 200mg/dL) and LDL-C (> 130mg/dL). Central adiposity
was apparent in 48%, 27% and 5% of participants using the following cut-points; 100cm2
MRI VATCSA, supine waist circumference 94cm (SCI-specific) and 102cm (NCEP),
Anthropometrics cutoffs and spinal cord injury
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Table 1. Participant demographics, injury characteristics, MRI outcomes, anthropometric measurements and biomarkers of cardiometabolic disease.
Total (n = 22) Paraplegic (n = 14) Tetraplegic (n = 8)
Demographics
Age (y) 36 ± 10 35 ± 9 37 ± 12
Injury Characteristics
Lesion Levela C5 –T11 T4 –T11 C5 –C7
Time Since Injurya (y) 8 ± 8 8 ± 9 8 ± 7
AnthropometricMeasurements
Body Mass (kg) 78.4 ± 13.4 80.3 ± 13.0 75.2 ± 14.3
BMI 24.9 ± 4.0 25.3 ± 3.5 24.1 ± 5.0
Seated Abdominal Circumference (cm) 100.3 ± 13.5 100.0 ± 14.9 100.8 ± 11.6
Seated Waist Circumference (cm) 88.8 ± 9.3 89.8 ± 10.9 87.0 ± 5.8
Supine Abdominal Circumference (cm) 87.6 ± 12.6 86.4 ± 11.8 89.8 ± 14.3
Supine Waist Circumference (cm) 85.9 ± 11.8 85.0 ± 11.6 87.5 ± 12.8
Supine Hip Circumference (cm) 97.5 ± 10.0 97.1 ± 10.0 98.2 ± 10.6
Waist:Hip Ratio 0.88 ± 0.09 0.88 ± 0.10 0.89 ± 0.08
MRI Outcomes
VATCSA (cm
2)a 100.4 ± 61.0 89.8 ± 63.0 117.5 ± 57.2
VAT Volume (cm3)a 5287 ± 3409 4550 ± 3327 6485 ± 3401
VATCSA/TOTAL
a 0.15 ± 0.08 0.10 ± 0.10 0.20 ± 0.10
VAT:SAT Ratioa 0.73 ± 0.44 0.69 ± 0.43 0.84 ± 0.44
Blood Pressure
SYS (mm/Hg) 117.2 ± 19.5 123.4 ± 18.0 106.4 ± 18.1
DIA (mm/Hg) 72.8 ± 9.9 75.2 ± 8.5 68.6 ± 11.4
Whole-body Outcomes
VO2 peak (L/min)
c 0.54 ± 0.20 0.61 ± 0.20 0.41 ± 0.12
BMR (Kcal/day) 1137 ± 280 1216 ± 278 1022 ± 240
Lipid Profile
LDL-C (mg/dL) 92.6 ± 26.9 89.3 ± 29.1 98.4 ± 23.2
HDL-C (mg/dL) 35.0 ± 8.1 36.1 ± 8.9 33.0 ± 6.5
Non-HDL (mg/dL) 115.1 ± 27.7 108.1 ± 30.8 127.4 ± 16.7
Total Cholesterol (mg/dL) 150.1 ± 29.0 144.3 ± 31.9 160.4 ± 21.1
TG (mg/dL) 111.1 ± 54.5 93.9 ± 37.6 141.1 ± 68.2
FFA (pg/mL) 363.7 ± 188.8 334.5 ± 178.6 394.1 ± 216.6
Carbohydrate Profile
HbA1c (%)a 5.40 ± 0.50 5.20 ± 0.40 5.60 ± 0.50
Si [(mu/L)^l.min^-1]
b 8.6 ± 6.3 10.5 ± 5.7 4.6 ± 6.1
Sg [min^-1] 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.00
Inflammatory Markers
CRP (ng/mL) 7221 ± 6574 7650 ± 6572 7393 ± 6953
TNF-α (pg/mL) 15.3 ± 8.0 15.5 ± 8.2 16 ± 8.2
IL-6 (pg/mL) 5.9 ± 6.8 6.9 ± 7.7 5.0 ± 5.4
Basal metabolic rate; BMR, body mass index; BMI, c-reactive protein; CPR, cross-sectional area; CSA, diastolic blood pressure; DIA, free fatty acid; FFA, glucose
effectiveness; Sg, glycated hemoglobin; HbA1c, high-density lipoprotein cholesterol; HDL-C, insulin sensitivity; Si, interleukin-6; IL-6, low-density lipoprotein
cholesterol; LDL-C, magnetic resonance imaging; MRI, peak oxygen uptake; VO2 peak, subcutaneous adipose tissue; SAT, systolic blood pressure; SYS, triglycerides;
TG, tumor necrosis factor alpha; TNF-α, visceral adipose tissue cross-sectional area; VATCSA. Missing data:
a n = 21
b n = 19
c n = 15.
https://doi.org/10.1371/journal.pone.0203049.t001
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respectively. Moreover, fifty-nine percent of participants were at high risk of developing future
coronary events (CRP > 3000ng/mL).
Age as a covariate
Age was significantly (P< 0.01) associated with anthropometric (seated and supine waist and
abdominal circumferences) (r = 0.66–0.70) and MRI indices (r = 0.69–0.82) of central adipos-
ity. Age was also positively associated with TG (r = 0.52, P< 0.05) and HbA1c (r = 0.47,
P< 0.05), and negatively associated with VO2 peak (r = -0.66, P< 0.01) and Si (r = -0.48,
P< 0.05).
Magnetic-resonance imaging outcomes and biomarkers of cardiometabolic
disease
Pearson correlations and part correlations (accounting for age) between MRI outcomes and
biomarkers of cardiometabolic disease are shown in Table 2. All MRI outcomes of central adi-
posity are positively associated with HbA1c (r = 0.47–0.69, P< 0.05) and TG (r = 0.50–0.59,
P< 0.05). Significant negative associations (P< 0.05) were observed between all MRI out-
comes; Si and VO2 peak (except for VAT:SAT ratio). HDL-C was negatively correlated with
CSA/total and VAT:SAT ratio, the later association remaining significant when accounting for
age (r = -0.39, P< 0.05). After accounting for age, there were significant associations
(P< 0.05) between TNF-α; VATCSA and VAT volume of r = 0.46 and r = 0.48, respectively.
Magnetic-resonance imaging outcomes and anthropometric measurements
of trunk adiposity
Seated and supine abdominal circumferences showed similar (P< 0.01) associations with
VATCSA (r = 0.81 and 0.78, respectively) and VAT volume (r = 0.82 and 0.79, respectively).
Compared to seated waist circumference, supine waist circumferences were more strongly
associated with VATCSA (r = 0.79 vs. r = 0.70) and VAT volume (r = 0.80 vs. r = 0.68). Supine
hip circumference was not significantly (P> 0.05) associated to measurements of VAT. The
only anthropometric index significantly associated with VAT:SAT ratio was waist:hip ratio
(r = 0.74, P< 0.01). The seated waist circumference cutoffs for a VATCSA of 100cm2, estimated
from the developed regression equations, are presented in Fig 1.
Anthropometric measurements of trunk adiposity and biomarkers of
cardiometabolic disease
Supine anthropometric measurements of central adiposity demonstrated consistent, moderate
and large associations with lipid profile components (Table 3). Most of these associations
remained significant even when accounting for age. Seated abdominal circumference and
supine abdominal and waist circumferences revealed moderate negative correlations with Si
(range; r = -0.45 –-0.49, P< 0.05), while seated waist circumference had small correlations (r =
-0.29, P> 0.05). There were also significant part correlations, accounting for age, between
TNF-α and anthropometric measurements of central adiposity (range; r = 0.48–0.56,
P< 0.05).
Differences in biomarkers of cardiometabolic disease using central obesity
cutoffs
VATCSA and supine waist circumferences were significantly associated with specific biomark-
ers of cardiometabolic disease (Table 3). Participants were dichotomized into two groups
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using either established (Fig 2) or population-specific cutoffs (Fig 3). Participants with
VATCSA cutoff 100cm
2 had significantly greater TG (P = 0.036) and HbA1c (P = 0.020), and
reduced Si values (P = 0.021) (Fig 2). Participants with VATCSA 100cm2 also had lower VO2
peak than those with central adiposity < 100cm2. Using our specific supine waist circumfer-
ence cutoff point of 86.5cm, TG and Si were significantly (P< 0.05) different between both
dichotomized groups (Fig 3). Table 4 also compares central adiposity and cardiometabolic dis-
ease risk factors between groups dichotomized using cutoffs generated for other anthropomet-
ric measurements.
Discussion
The current study was undertaken to propose various anthropometric cutoffs capable of dis-
tinguishing those who are at risk of developing central obesity and cardiometabolic disorders
after SCI. Central obesity has previously been defined in men as a waist circumference mea-
surement greater than 102cm [11]. Both seated or supine waist and abdominal circumferences
Table 2. Linear regression models were used to find Pearson correlation coefficients and part correlations, with adjustments for age as a covariate, between mag-
netic-resonance imaging outcomes of central adiposity and biomarkers of cardiometabolic disease.
Pearson correlation coefficients (r) Part correlation coefficients (r), accounting for age
VATCSA (cm
2) VAT volume (cm3) CSA/Total VAT:SAT VATCSA (cm
2) VAT volume (cm3) CSA/Total VAT:SAT
Blood Pressure
SYS 0.01 0.08 -0.10 -0.15 -0.18 -0.05 -0.35 -0.25
DIA 0.32 0.33 0.34 0.37 0.08 0.11 0.11 0.14
Whole body physiology
VO2 peak -0.62† -0.60† -0.64† -0.51 -0.07 -0.09 -0.08 0.00
BMR -0.37 -0.30 -0.46† -0.44 -0.22 -0.10 -0.37 -0.31
Lipid profile
LDL-C 0.05 0.02 -0.05 -0.28 0.19 0.13 0.03 -0.22
HDL-C -0.39 -0.38 -0.49† -0.60 -0.21 -0.20 -0.40 -0.39†
Non-HDL 0.29 0.28 0.21 0.03 0.28 0.24 0.13 -0.09
Total cholesterol 0.17 0.16 0.06 -0.14 0.21 0.18 0.01 -0.19
TG+ 0.51† 0.50† 0.59 0.57 0.17 0.15 0.30 0.25
FFA 0.33 0.35 0.31 0.22 0.45 0.44 0.41 0.16
Carbohydrate Profile
HbA1c 0.49† 0.47† 0.56† 0.69 0.19 0.16 0.31 0.40†
Si
+ -0.53† -0.55† -0.66 -0.56† -0.27 -0.31 -0.51† -0.24
Sg
+ -0.08 -0.07 -0.23 -0.42 0.17 0.13 -0.10 -0.27
Inflammatory markers
CRP+ 0.20 0.23 0.28 -0.01 0.11 0.17 0.24 -0.13
TNF-α+ 0.30 0.33 0.30 0.13 0.46† 0.48† 0.44 0.10
IL-6- 0.04 0.10 0.09 0.07 0.16 0.25 0.23 0.12
Basal metabolic rate; BMR, c-reactive protein; CRP, cross-sectional area; CSA, diastolic blood pressure; DIA, free fatty acid; FFA, glucose effectiveness; Sg, glycated
hemoglobin; HbA1c, high-density lipoprotein cholesterol; HDL-C, insulin sensitivity; Si, interleukin-6; IL-6, low-density lipoprotein cholesterol; LDL-C, peak oxygen
uptake; VO2 peak, triglycerides; TG, tumor necrosis factor alpha; TNF-α, subcutaneous adipose tissue; SAT, systolic blood pressure; SYS, Visceral adipose tissue cross-
sectional area; VATCSA.
+ positive skew (data was log transformed prior to analysis)
- negative skew (data was reflected and log transformed prior to analysis).
†P < 0.05
P < 0.01.
https://doi.org/10.1371/journal.pone.0203049.t002
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were strongly associated with VAT and VAT:SAT ratio as measured by the gold standard
MRI. However, it is important to identify population specific cutoffs for either seated or supine
anthropometrics to identify individuals with elevated VAT and increased cardiometabolic dis-
ease risk. These cutoffs were 86.5cm and 88.3cm for supine waist and abdominal, respectively,
as well as 89.1cm and 101cm for seated waist and abdominal, respectively. Both seated and
supine anthropometrics are tightly associated with lipid profile and low grade inflammation
(i.e. TNF-α), independent of age in persons with SCI. Parallel associations were established
between VAT and cardiometabolic disease risk (HDL-C, HBA1c and TNF-α). Finally, the
established supine waist circumference cutoff clearly distinguished between those who are at
an increased risk of central adiposity, insulin resistance and dyslipidemia.
Cardiometabolic disorders are considered serious sequalae after of SCI. Approximately,
50–75% present with impaired glucose tolerance and are at high risk of developing type II dia-
betes mellitus [7]. Furthermore, 75% are at high risk of developing dyslipidemia, with 50% at
risk of developing metabolic syndrome [29, 30]. These comorbidities are likely to impact qual-
ity of life and impose socioeconomic burden after SCI. Central adiposity characterized by
increasing waist circumference, VATCSA or VAT:SAT ratio has been shown to be tightly asso-
ciated with cardiometabolic disorders after SCI. Maki et al. and Nightingale et al. also found
that waist circumference was correlated with TG and negatively correlated with serum HDL-C
[18, 31] in persons with SCI. Controversies have been raised regarding the use of waist circum-
ference as a surrogate for VATCSA in persons with SCI [10, 23]. However, in the current study,
anthropometric measurements were tightly associated with VAT indices either during supine
or seated positioning. VAT is tightly associated with indices of insulin resistance as quantified
Fig 1. Associations between magnetic-resonance imaging (MRI) visceral adipose tissue cross-sectional area (VATCSA) and anthropometric
measurements of central adiposity; seated abdominal (A) and waist (B) circumference and, supine abdominal (C) and waist (D) circumference.
Lines of best fit (fixed) are shown for each correlation, along with Pearson correlation co-efficient values (r), significance (P) and specific linear
regression equations. Population specific cutoffs, corresponding to 100cm2 VATCSA, are highlighted by the dashed lines.
https://doi.org/10.1371/journal.pone.0203049.g001
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by single slice CT scan [9, 10] and multi-axial MRI [23]. Moreover, VAT has previously been
negatively associated with HDL-C in persons with SCI [11]. Anecdotal evidence supports the
hypothesis that VATCSA > 100cm
2 is likely to promote a more pro-inflammatory state [32]
due to the infiltration of immune cells (macrophages and T lymphocytes), which secrete
inflammatory cytokines such as TNF-α and IL-6 [33, 34]. Therefore, the first prophylactic line
of defense is establishing cutoffs that will flag those who are risk of developing cardiometabolic
disorders after SCI.
Persons with SCI are likely to consume high fat diet; a predisposing lifestyle factor for dysli-
pidemia, central adiposity and insulin resistance [5, 23, 35, 36]. Groah et al, (2009) found that
persons with paraplegia and tetraplegia consume 81.4g and 82.7g of fat per day, respectively,
while the recommended daily intake for able-bodied individuals is 40-70g/d [35]. Elevated
VAT was associated with impaired Si, calculated following the injection of a glucose bolus
directly into the circulation. IVGTT measurements likely offer improved measurement of
peripheral insulin resistance (i.e. adipose tissue and skeletal muscle). To our knowledge, this is
Table 3. Linear regression models were used to find Pearson correlation coefficients and part correlations, with adjustments for age as a covariate, between anthro-
pometric measurements of central adiposity and biomarkers of cardiometabolic disease.
Pearson correlation coefficients (r) Part correlation coefficients, accounting for age
Seated Supine Seated Supine
AC (cm) WC (cm) AC (cm) WC (cm) HC (cm) Waist:hip ratio AC (cm) WC (cm) AC (cm) WC (cm) HC (cm) Waist:hip ratio
Blood Pressure
SYS 0.05 0.19 0.11 0.19 0.27 -0.01 0.04 0.24 0.13 0.24 0.27 -0.04
DIA 0.10 0.23 0.09 0.25 -0.07 0.44† -0.12 0.08 -0.11 0.09 -0.15 0.37
Whole-body Physiology
VO2 peak -0.05 0.15 -0.40 -0.44 -0.22 -0.39 -0.05 0.15 0.06 0.06 -0.05 0.16
BMR -0.08 0.06 -0.05 -0.07 0.32 -0.23 0.17 0.33 0.18 0.38 0.42† -0.04
Lipid Profile
LDL-C 0.35 0.42 0.33 0.33 0.48† -0.03 0.55 0.61 0.50† 0.54† 0.51† 0.02
HDL-C -0.16 -0.11 -0.06 -0.08 0.21 -0.34 0.07 0.12 0.19 0.20 0.31 -0.18
Non-HDL 0.55 0.53† 0.50† 0.51† 0.49† 0.20 0.58 0.54† 0.50† 0.54† 0.46† 0.10
Total cholesterol 0.48† 0.47† 0.46† 0.47† 0.53† 0.10 0.58 0.55† 0.53† 0.57 0.52† 0.04
TG+ 0.51† 0.34 0.44† 0.45† 0.09 0.53† 0.19 -0.09 0.11 0.10 -0.07 0.22
FFA 0.10 0.09 0.17 0.20 -0.10 0.36 0.09 0.08 0.15 0.19 -0.14 0.44
Carbohydrate Profile
HbA1c 0.29 0.16 0.20 0.27 -0.16 0.52† -0.07 -0.22 -0.16 -0.11 0.31 0.24
Si
+ -0.49† -0.29 -0.47† -0.45† -0.16 -0.44 -0.18 0.13 -0.14 -0.07 0.01 -0.08
Sg
+ 0.11 0.09 0.14 0.07 0.35 -0.24 0.31 0.27 0.33 0.26 0.41 -0.20
Inflammatory markers
CRP+ 0.18 0.09 0.10 0.10 0.02 0.13 0.13 0.01 0.17 0.21 0.05 0.21
TNF-α+ 0.44† 0.43 0.36 0.38 0.25 0.28 0.51† 0.48† 0.49† 0.56 0.27 0.37
IL-6- -0.02 -0.05 -0.05 -0.09 -0.03 -0.08 0.04 -0.01 0.09 0.06 0.03 0.05
Abdominal circumference; AC, basal metabolic rate; BMR, c-reactive protein; CRP, diastolic blood pressure; DIA, free fatty acid; FFA, glucose effectiveness; Sg, glycated
hemoglobin; HbA1c, high-density lipoprotein cholesterol; HDL-C, hip circumference; HC, insulin sensitivity; Si, interleukin 6; IL-6, low density lipoprotein cholesterol;
LDL-C, peak oxygen uptake; VO2 peak, systolic blood pressure; SYS, triglycerides; TG, tumor necrosis factor alpha; TNF-α, waist circumference; WC.
+ positive skew (data was log transformed prior to analysis)
- negative skew (data was reflected and log transformed prior to analysis).
†P < 0.05
 P < 0.01.
https://doi.org/10.1371/journal.pone.0203049.t003
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Fig 2. Differences in cardiometabolic disease risk biomarkers [triglycerides (TG) (A), insulin sensitivity (Si) (B), glycated hemoglobin
(HbA1c) (C) and peak oxygen uptake (VO2 peak) (D) among participants dichotomized per multi-axial magnetic resonance imaging (MRI)
visceral adipose tissue cross-sectional area (VATCSA) (< 100cm
2, n = 11; 100cm2, n = 10). P values are shown for significant differences
(P< 0.05).
https://doi.org/10.1371/journal.pone.0203049.g002
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the first study to demonstrate associations with indices of VAT and a more sensitive measure
of peripheral insulin resistance after SCI. Insulin resistance leads to a decreased suppression of
lipolysis in adipocytes, resulting in elevated concentrations of FFA in the systemic circulation.
Fig 3. Differences in cardiometabolic disease risk biomarkers [triglycerides (TG) (E), insulin sensitivity (Si) (F), total cholesterol (G),
Non-HDL (H) among participants dichotomized per the derived supine waist circumference cutoff for central adiposity (< 86.5cm,
n = 12; 86.5cm, n = 10). P values are shown for significant differences (P< 0.05).
https://doi.org/10.1371/journal.pone.0203049.g003
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Table 4. Generated population specific seated/supine AC and WC cutoff points with averaged and standard deviation for the cardiometabolic risk factors chosen in
the current study.
Seated Supine
Anthropometric
Measurements
AC < 101
(cm)
AC 101
(cm)
WC < 89.1
(cm)
WC 89.1
(cm)
AC < 88.3
(cm)
AC 88.3
(cm)
WC < 86.5
(cm)
WC 86.5
(cm)
Body Mass (kg) 72.3 ± 11.7 84.6 ± 12.6† 72.3 ± 11.2 85.9 ± 12.5† 72.3 ± 11.7 84.6 ± 12.6† 72.6 ± 11.2 85.4 ± 13†
BMI (cm) 22.2 ± 3.6 27.5 ± 2.4 22.6 ± 3.6 27.6 ± 2.7 22.2 ± 3.6 27.5 ± 2.4 22.43± 3.5 27.8 ± 2.3
Seated AC (cm) 89.7 ± 9.2 111.0 ± 6.9 91.3 ± 10.1 111.1 ± 7.9 89.7 ± 9.2 111.0 ± 6.9 90.7 ± 9.5 118.8 ± 6.6
Seated WC (cm) 81.6 ± 5.8 96.0 ± 5.9 81.8 ± 5.4 97.2 ± 4.8 81.6 ± 5.8 96.0 ± 5.9 82.0 ± 5.7 97.0 ± 5.2
Supine AC (cm) 77.3 ± 7.8 97.9 ± 6.1 79.3 ± 9.5 97.6 ± 7.4 77.3 ± 7.8 97.9 ± 6.1 78.7 ± 8.9 98.3 ± 6.3
Supine WC (cm) 76.0 ± 6.6 95.8 ± 5.8 77.4 ± 7.8 96.1 ± 6.3 76.0 ± 6.6 95.8 ± 5.8 76.8 ± 6.9 96.8 ± 5.0
Supine HC (cm) 92.3 ± 6.7 102.7 ± 10.1† 92.7 ± 6.7 103.2 ± 10.5† 92.3 ± 6.7 102.7 ± 10.1† 92.8 ± 6.7 103.2 ± 10.6†
Waist:Hip ratio 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1
MRI Outcomes
MRI VATcsa (cm
2) a 53.3 ± 35.2 143.2 ± 45.6 64.4 ± 55.4 139.9 ± 39.0 53.3 ± 35.2 143.2 ± 45.6 52.6 ± 33.4 152.9 ± 33.9
MRI VAT Volume (cm3) a 3154 ± 2252 7578 ± 2665 3413 ± 3051 7932 ± 1966 2767 ± 2111 7873 ± 2604 2690 ± 2018 8143 ± 1997
MRI VATcsa/Total
a 0.09 ± 0.06 0.19 ± 0.07 0.11 ± 0.08 0.19 ± 0.05† 0.09 ± 0.06 0.19 ± 0.07 0.09 ± 0.05 0.20 ± 0.06
MRI VAT:SAT ratio a 0.52 ± 0.27 0.86 ± 0.44† 0.58 ± 0.38 0.83 ± 0.40 0.52 ± 0.27 0.86 ± 0.44† 0.50 ± 0.26 0.92 ± 0.42†
Blood Pressure
SYS (mm/Hg) 116 ± 21 119 ± 19 117 ± 19 117 ± 21 116 ± 21 119 ± 19 116 ± 20 119 ± 20
DIA (mm/Hg) 71 ± 10 74 ± 11 72 ± 10 74 ± 10 81 ± 14 74 ± 11 71 ± 9 76 ± 10
Whole-body Outcomes
VO2 peak (L/min)
c 0.65 ± 0.23 0.48 ± 0.17 0.59 ± 0.23 0.51 ± 0.19 0.65 ± 0.23 0.48 ± 0.17 0.65 ± 0.20 0.46 ± 0.17
BMR (Kcal/day) 1058 ± 227 1215 ± 316 1051 ± 218 1240 ± 321 1058 ± 227 1215 ± 316 1053 ± 217 1238 ± 324
Lipid Profile
LDL-C (mg/dL) 85.1 ± 19.3 100.1 ± 32.0 86.6 ± 22.3 99.8 ± 31.2 85.1 ± 19.3 100.1 ± 32.0 88.08 ± 21.1 98 ± 32.9
HDL-C (mg/dL) 35.8 ± 9.2 34.2 ± 7.2 35.3 ± 9.2 34.7 ± 7.0 35.8 ± 9.2 34.2 ± 7.2 35.9 ± 8.8 33.9 ± 7.5
Non-HDL (mg/dL) 102.1 ± 23.0 128.2 ± 26.7† 105.7 ± 25.5 126.5 ± 27.1 102.1 ± 23.0 128.2 ± 26.7† 105.8 ± 25.5 126.3 ± 27.3
Total Cholesterol (mg/dL) 137.9 ± 20.6 162.4 ± 31.9† 140.9 ± 24.1 161.2 ± 31.7 137.9 ± 20.6 162.4 ± 31.9† 141.8 ± 23.7 160.2 ± 32.8
TG (mg/dL) 85.1 ± 25.0 137.0 ± 64.2† 95.3 ± 38.6 129.9 ± 66.2 85.1 ± 25.0 137.0 ± 64.2† 88.8 ± 26.9 137.9 ± 67.6
FFA (pg/mL) 354.2 ± 193.5 373.2 ± 192.8 353.8 ± 201.3 375.6 ± 182.5 354.2 ± 193.5 373.2 ± 192.8 335.25 ± 195.8 397.8 ± 184.1
Carbohydrate Profile
HbA1c (%) a 5.21 ± 0.26 5.47 ± 0.57 5.2 ± 0.24 5.54 ± 0.61 5.21 ± 0.26 5.47 ± 0.57 5.2 ± 0.25 5.51 ± 0.58
Si [(mu/L)^l.min^-1]
b 11.6 ± 6.3 5.9 ± 5.1† 11.6 ± 6.3 5.3 ± 4.4† 11.6 ± 6.3 5.9 ± 5.1† 11.9 ± 6.0 5.0 ± 4.5†
Sg [min^-1] 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01
Inflammatory Markers
CRP (ng/mL) 5774 ± 6841 8668 ± 6273 6420 ± 6846 8182 ± 6457 5774 ± 6841 8668 ± 6273 5455 ± 6615 9340 ± 6182
TNF-α (pg/mL) 11.7 ± 5.6 19.0 ± 8.5† 12.7 ± 6.8 18.5 ± 8.4 11.7 ± 5.6 19.0 ± 8.5† 11.3 ± 5.4 20.1 ± 8.1†
IL-6 (pg/mL) 4.9 ± 4.9 6.9 ± 8.4 6.0 ± 5.8 5.8 ± 8.1 4.9 ± 4.9 6.9 ± 8.4 4.6 ± 4.8 7.5 ± 8.6
Abdominal circumference; AC, basal metabolic rate; BMR, body mass index; BMI, c-reactive protein; CPR, cross-sectional area; CSA, diastolic blood pressure; DIA, free
fatty acid; FFA, glucose effectiveness; Sg, glycated hemoglobin; HbA1c, high-density lipoprotein; HDL-C, hip circumference; HC, insulin sensitivity; Si, interleukin-6; IL-
6, low-density lipoprotein; LDL-C, magnetic resonance imaging; MRI, peak oxygen uptake; VO2 peak, subcutaneous adipose tissue; SAT, systolic blood pressure; SYS,
triglycerides; TG, tumor necrosis factor alpha; TNF-α, visceral adipose tissue cross sectional area; VATCSA, waist circumference; WC. Missing data:
a n = 21
b n = 19
c n = 15.
†P < 0.05
P < 0.01.
https://doi.org/10.1371/journal.pone.0203049.t004
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This creates a vicious cycle which further exacerbates insulin resistance in the liver and skeletal
muscle [37]. In support of this, the current data demonstrated a strong negative association
between FFA and Sg (r = -0.57, P = 0.007). Thus, the mechanisms behind VATs contribution
to elevated insulin resistance may be related to its higher rate of lipolytic activity (i.e. increased
flux of free fatty acids (FFA)) and/or its anatomical location (i.e. FFA output directly to the
liver via the hepatic portal vein) [38]. In support of this notion, liver adiposity was found to be
tightly associated with VAT, TG and non-HDL-C in persons with SCI. The increase in liver
adiposity was also positively associated with fasting plasma glucose concentrations and
HbA1c, and negatively associated with Si [39].
With respect to lipid profile, the atherogenic effects observed in persons with SCI are well
established [7,11,40]. The amplified risk of coronary heart disease in this population is likely a
function of reduced HDL-C [41]. VAT promotes a more pro-inflammatory state [32] due to
the infiltration of immune cells (macrophages and T lymphocytes) that secrete inflammatory
cytokines such as TNF-α and IL-6 [33, 34]. The data herein, shows indices of central adiposity
are positively associated with TNF-α after accounting for age. It is possible that the etiology of
depressed HDL-C in persons with SCI is a result of the direct relationship between endothelial
lipase (EL) and inflammatory cytokines (including TNF-α) [42, 43]. EL plays a role in the
clearance of HDL-C from the circulation, by catalyzing the hydrolysis of HDL-C phospholip-
ids [41], thereby linking chronic low-grade inflammation and lipid abnormalities in persons
with SCI. Gorgey et al. also demonstrated a very large (r = 0.75) correlation between VAT and
TG. This current study supports this association, with a large (r = 0.51) correlation between
VATCSA and TG, and a similar correlation (r = 0.45) between supine waist circumference and
TG. Additionally, low plasma HDL-C concentrations could also be associated with physical
inactivity, which is commonly linked to chronic systemic inflammation and increased VAT
accumulation [41]. Considering the nearly perfect (r = 0.82) association between age and
VATCSA, persons aging with SCI and central adiposity are at increased risk of metabolic
abnormalities and should therefore be the focus of future research efforts in this population.
Establishing SCI specific anthropometric cutoffs may likely detect, earlier, those who have
heightened risks of developing cardiometabolic disorders. This may also allow clinicians to
provide early feedback about lifestyle behaviors (dietary habits and exercise). Anthropometric
measurements have previously been used as a surrogate measure to estimate VAT accumula-
tion in persons with SCI. Edwards et al. found that supine waist circumference at three loca-
tions (lowest rib, iliac crest and the midpoint between the lowest rib and iliac crest) was
associated to VATCSA (r> 0.90) in persons with SCI [10]. Significant correlations were noted
in the current study between anthropometric measurements of central adiposity and VATCSA,
which permitted the development of the seated/supine abdominal and waist circumference
cutoffs, extrapolated from 100cm2 MRI VATCSA. Previous research proposed that persons
with SCI have 42% more VAT per cm of waist circumference than their able-bodied counter-
parts [10]. Therefore, using able-bodied cutoff points would misclassify many of the SCI popu-
lation as low risk for cardiometabolic risk factors.
Limitations
This study is limited by its cross-sectional design and small sample size. Thus, it is not possible
to infer causality. However, the plethora of associations assessed, along with the use of both
gold-standard imaging techniques and anthropometric measurements of central adiposity
provides useful data to inform the assessment of obesity in persons with SCI. Although this
study lacks generalizability to females with SCI, significant differences in VAT accumulation
has been shown between the sexes (males 1.8–2.6 times greater VATCSA than females) [44],
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which may explain why men display elevated CVD risk profiles [45]. Consequently, to ensure
a more homogenous population only males were recruited for this current study. Such associa-
tions remain to be assessed specifically in females with SCI. It is not possible to comment on
the role of physical activity in increased cardiometabolic disease risk in this population, as this
variable was not measured in the current study. However, a recent study demonstrated that
body composition variables, and not level of physical activity, may explain poor metabolic pro-
file after SCI [18]. Previous cross-sectional research advocated accounting for age to better
understand the associations between central adiposity and biomarkers of cardiometabolic dis-
ease in persons with SCI [11]. Considering that VAT has been shown to be increased in mid-
dle-aged men in comparison to younger adults [46], also accounting for age as a covariate is a
notable strength of this study.
Level of injury also plays a role in the accumulation of VAT as seen in Table 1. While para-
plegic and tetraplegic participants had similar waist circumference measurements, VAT mea-
surements differed between the groups. Participants with paraplegia on average had VATCSA
89.8cm2 while those with tetraplegia had on average VATCSA 117.5cm
2. Future studies will
therefore need to develop new waist circumference cutoffs to account for the differences
between these two groups. Additionally, this is a small male cohort, with a mixture of 41% vet-
erans and 59% non-veterans. Future studies are required to ascertain the validity of the newly
developed anthropometric prediction equations across a larger cohort and females with SCI.
Conclusion
Considering the deleterious impact of central adiposity on cardiometabolic health, as eluded
to herein, it is imperative that researchers develop strategies to reduce VAT in persons with
SCI. In the able-bodied population, the combination of regular physical activity and dietary
manipulation (to generate a sustainable energy deficit) is the cornerstone of obesity and type II
diabetes mellitus management [47, 48]. Considering how prevalent such conditions are in per-
sons with SCI, we advocate a renewed impetus to expand upon the limited existing evidence-
base concerning the combination of diet and exercise, to reduce VAT and promote concomi-
tant improvements in cardiometabolic health in this population. The proposed cutoffs herein
may better identify persons at risk of chronic cardiometabolic diseases than those used previ-
ously, specific to certain ethnicities. Determining whether men with SCI exceed these pro-
posed site specific anthropometric cutoffs might help facilitate earlier identification of persons
at increased risk of developing cardiometabolic diseases. Future studies are necessary to cross-
validate our proposed anthropometric cutoffs of central adiposity in persons with SCI and
ascertain their validity in a larger sample size as well as in a female cohort. It is hoped progress
in this area allows practitioners to more easily and better identify persons at increased risk of
chronic diseases and provide early prevention guidance.
Acknowledgments
We would like to thank Dr. Laura O’Brien and Chase Wade in the Spinal Cord Injury and Dis-
orders Service for their assistance with basal metabolic rate, anthropometric measurements
and image analysis. We are also indebted to our research coordinator, Refka Khalil for her
help with participant recruitment. We are thankful to the Hunter Holmes McGuire Research
Institute and Virginia Commonwealth University (VCU) Clinical Research Service for provid-
ing appropriate environments to conduct clinical human research trials. This work was sup-
ported by the Veteran Affairs, Veteran Health Administration, Rehabilitation Research and
Development Service (VA-RRD CDA2: B7867-W). We are also grateful to the study partici-
pants for their time and effort.
Anthropometrics cutoffs and spinal cord injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0203049 August 31, 2018 15 / 18
Author Contributions
Conceptualization: Ashraf S. Gorgey.
Data curation: Ashraf S. Gorgey.
Formal analysis: Ryan M. Sumrell, Thomas E. Nightingale, Ashraf S. Gorgey.
Funding acquisition: Ashraf S. Gorgey.
Investigation: Ashraf S. Gorgey.
Methodology: Ashraf S. Gorgey.
Project administration: Ashraf S. Gorgey.
Resources: Ashraf S. Gorgey.
Software: Ashraf S. Gorgey.
Supervision: Ashraf S. Gorgey.
Validation: Ashraf S. Gorgey.
Writing – original draft: Ryan M. Sumrell, Thomas E. Nightingale, Ashraf S. Gorgey.
Writing – review & editing: Ryan M. Sumrell, Thomas E. Nightingale, Liron S. McCauley,
Ashraf S. Gorgey.
References
1. Liou TH, Pi-Sunyer FX, Laferrère B. Physical disability and obesity. Nutr Rev. 2005; 63(10):321–31.
PMID: 16295145
2. Gater DR. Obesity after spinal cord injury. Phys Med Rehabil Clin N Am. 2007; 18(2):333–51, vii.
https://doi.org/10.1016/j.pmr.2007.03.004 PMID: 17543776
3. Rimmer JH, Schiller W, Chen MD. Effects of disability-associated low energy expenditure decondition-
ing syndrome. Exerc Sport Sci Rev. 2012; 40(1):22–9. https://doi.org/10.1097/JES.0b013e31823b8b82
PMID: 22016146
4. Gorgey AS, Dolbow DR, Dolbow JD, Khalil RK, Castillo C, Gater DR. Effects of spinal cord injury on
body composition and metabolic profile—part I. J Spinal Cord Med. 2014; 37(6):693–702. https://doi.
org/10.1179/2045772314Y.0000000245 PMID: 25001559
5. Nightingale TE, Williams S, Thompson D, Bilzon JLJ. Energy balance components in persons with para-
plegia: daily variation and appropriate measurement duration. Int J Behav Nutr Phys Act. 2017; 14
(1):132. https://doi.org/10.1186/s12966-017-0590-z PMID: 28950900
6. Feasel S, Groah S. The Impact of Diet on Cardiovascular Disease Risk in individuals with Spinal Cord
Injury. Topics in Spinal Cord Injury Rehabilitation. Topics in Spinal Cord Injury Rehabilitation. 2009; 14
(3): 58–68.
7. Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal
Cord Med. 2001; 24(4):266–77. PMID: 11944785
8. Lavela SL, Weaver FM, Goldstein B, Chen K, Miskevics S, Rajan S, et al. Diabetes mellitus in individu-
als with spinal cord injury or disorder. J Spinal Cord Med. 2006; 29(4):387–95. PMID: 17044389
9. Maruyama Y, Mizuguchi M, Yaginuma T, Kusaka M, Yoshida H, Yokoyama K, et al. Serum leptin,
abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury. Spinal
Cord. 2008; 46(7):494–9. https://doi.org/10.1038/sj.sc.3102171 PMID: 18209743
10. Edwards LA, Bugaresti JM, Buchholz AC. Visceral adipose tissue and the ratio of visceral to subcutaneous
adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist cir-
cumferences. Am J Clin Nutr. 2008; 87(3):600–7. https://doi.org/10.1093/ajcn/87.3.600 PMID: 18326597
11. Gorgey AS, Mather KJ, Gater DR. Central adiposity associations to carbohydrate and lipid metabolism
in individuals with complete motor spinal cord injury. Metabolism. 2011; 60(6):843–51. https://doi.org/
10.1016/j.metabol.2010.08.002 PMID: 20870252
12. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on
hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
Metabolism. 1988; 37(1):15–21. PMID: 3275857
Anthropometrics cutoffs and spinal cord injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0203049 August 31, 2018 16 / 18
13. Radziuk J. Homeostastic model assessment and insulin sensitivity/resistance. Diabetes. 2014; 63
(6):1850–4. https://doi.org/10.2337/db14-0116 PMID: 24853901
14. Silveira SL, Ledoux TA, Robinson-Whelen S, Stough R, Nosek MA. Methods for classifying obesity in
spinal cord injury: a review. Spinal Cord. 2017; 55(9):812–7. https://doi.org/10.1038/sc.2017.79 PMID:
28695902
15. Executive summary of the third report of the national cholesterol education program (NCEP) expert
panel on detection, evaluation, and treatment of high cholesterol in adults (adult treatment panel III).
JAMA 2001; 285: 2486–2497. PMID: 11368702
16. Inayama T, Higuchi Y, Tsunoda N, Uchiyama H, Sakuma H. Associations between abdominal visceral
fat and surrogate measures of obesity in Japanese men with spinal cord injury. Spinal Cord. 2014; 52
(11):836–41. https://doi.org/10.1038/sc.2014.162 PMID: 25266697
17. Ravensbergen HR, Lear SA, Claydon VE. Waist circumference is the best index for obesity-related car-
diovascular disease risk in individuals with spinal cord injury. J Neurotrauma. 2014; 31(3):292–300.
https://doi.org/10.1089/neu.2013.3042 PMID: 24070685
18. Nightingale TE, Walhin JP, Thompson D, Bilzon JL. Biomarkers of cardiometabolic health are associ-
ated with body composition characteristics but not physical activity in persons with spinal cord injury. J
Spinal Cord Med. 2017:1–10.
19. Gorgey AS, Khalil RE, Gill R, O’Brien LC, Lavis T, Castillo T, et al. Effects of Testosterone and Evoked
Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled
trial. BMJ Open. 2017; 7(4):e014125. https://doi.org/10.1136/bmjopen-2016-014125 PMID: 28377392
20. Gorgey AS, Chiodo AE, Zemper ED, Hornyak JE, Rodriguez GM, Gater DR. Relationship of spasticity
to soft tissue body composition and the metabolic profile in persons with chronic motor complete spinal
cord injury. J Spinal Cord Med. 2010; 33(1):6–15. PMID: 20397439
21. Gorgey AS, Martin H, Metz A, Khalil RE, Dolbow DR, Gater DR. Longitudinal changes in body composi-
tion and metabolic profile between exercise clinical trials in men with chronic spinal cord injury. J Spinal
Cord Med. 2016; 39(6):699–712. https://doi.org/10.1080/10790268.2016.1157970 PMID: 27077574
22. Buchholz AC, Bugaresti JM. A review of body mass index and waist circumference as markers of obe-
sity and coronary heart disease risk in persons with chronic spinal cord injury. Spinal Cord. 2005; 43
(9):513–8. https://doi.org/10.1038/sj.sc.3101744 PMID: 15824757
23. Gorgey AS, Mather KJ, Cupp HR, Gater DR. Effects of resistance training on adiposity and metabolism
after spinal cord injury. Med Sci Sports Exerc. 2012; 44(1):165–74. https://doi.org/10.1249/MSS.
0b013e31822672aa PMID: 21659900
24. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium:
a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sam-
pled intravenous glucose tolerance test. Diabetes Technol Ther. 2003; 5(6):1003–15. https://doi.org/10.
1089/152091503322641060 PMID: 14709204
25. Gorgey AS, Mather KJ, Poarch HJ, Gater DR. Influence of motor complete spinal cord injury on visceral
and subcutaneous adipose tissue measured by multi-axial magnetic resonance imaging. J Spinal Cord
Med. 2011; 34(1):99–109. https://doi.org/10.1179/107902610X12911165975106 PMID: 21528633
26. Gorgey AS, Lawrence J. Acute Responses of Functional Electrical Stimulation Cycling on the Ventila-
tion-to-CO2 Production Ratio and Substrate Utilization After Spinal Cord Injury. PM R. 2016; 8(3):225–
34. https://doi.org/10.1016/j.pmrj.2015.10.006 PMID: 26493854
27. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: L. Erlbaum
Associates; 1988. xxi, 567 p. p.
28. McGraw K. O., Wong S. P. A common language effect-size statistic. Psychological Bulletin. 1992;
111:361–365.
29. Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia
or quadriplegia: a model of premature aging. Metabolism. 1994; 43(6):749–56. PMID: 8201966
30. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance
due to insulin resistance in patients with spinal cord injuries. Diabetes. 1980; 29(11):906–10. PMID:
7429029
31. Maki KC, Briones ER, Langbein WE, Inman-Felton A, Nemchausky B, Welch M, et al. Associations
between serum lipids and indicators of adiposity in men with spinal cord injury. Paraplegia. 1995; 33
(2):102–9. https://doi.org/10.1038/sc.1995.24 PMID: 7753565
32. Bouloumie´ A, Curat CA, Sengenès C, Lolmède K, Miranville A, Busse R. Role of macrophage tissue
infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 2005; 8(4):347–54. PMID: 15930956
33. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and pri-
marily by the nonfat cells: a review. Mediators Inflamm. 2010; 2010:513948. https://doi.org/10.1155/
2010/513948 PMID: 20508843
Anthropometrics cutoffs and spinal cord injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0203049 August 31, 2018 17 / 18
34. Thompson D, Karpe F, Lafontan M, Frayn K. Physical activity and exercise in the regulation of human
adipose tissue physiology. Physiol Rev. 2012; 92(1):157–91. https://doi.org/10.1152/physrev.00012.
2011 PMID: 22298655
35. Groah SL, Nash MS, Ljungberg IH, Libin A, Hamm LF, Ward E, et al. Nutrient intake and body habitus
after spinal cord injury: an analysis by sex and level of injury. J Spinal Cord Med. 2009; 32(1):25–33.
PMID: 19264046
36. Gorgey AS, Caudill C, Sistrun S, Khalil RE, Gill R, Castillo T, et al. Frequency of Dietary Recalls, Nutri-
tional Assessment, and Body Composition Assessment in Men With Chronic Spinal Cord Injury. Arch
Phys Med Rehabil. 2015; 96(9):1646–53. https://doi.org/10.1016/j.apmr.2015.05.013 PMID: 26047531
37. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4
gene impairs insulin action in muscle and liver. Nature. 2001; 409(6821):729–33. https://doi.org/10.
1038/35055575 PMID: 11217863
38. Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol
Metab. 2008; 93(11 Suppl 1):S57–63.
39. Rankin KC, O’Brien LC, Segal L, Khan MR, Gorgey AS. Liver Adiposity and Metabolic Profile in Individ-
uals with Chronic Spinal Cord Injury. Biomed Res Int. 2017; 2017:1364818. https://doi.org/10.1155/
2017/1364818 PMID: 28948164
40. Bauman WA, Spungen AM. Coronary heart disease in individuals with spinal cord injury: assessment of
risk factors. Spinal Cord. 2008; 46(7):466–76. https://doi.org/10.1038/sj.sc.3102161 PMID: 18180789
41. Gilbert O, Croffoot JR, Taylor AJ, Nash M, Schomer K, Groah S. Serum lipid concentrations among per-
sons with spinal cord injury—a systematic review and meta-analysis of the literature. Atherosclerosis.
2014; 232(2):305–12. https://doi.org/10.1016/j.atherosclerosis.2013.11.028 PMID: 24468143
42. Hirata K, Ishida T, Matsushita H, Tsao PS, Quertermous T. Regulated expression of endothelial cell-
derived lipase. Biochem Biophys Res Commun. 2000; 272(1):90–3. PMID: 10872808
43. Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR, et al. Endothelial lipase is
associated with inflammation in humans. J Lipid Res. 2006; 47(12):2808–13. https://doi.org/10.1194/jlr.
P600002-JLR200 PMID: 16980590
44. Gorgey AS, Farkas GJ, Dolbow DR, Khalil RE, Gater DR. Gender Dimorphism in Central Adiposity May
Explain Metabolic Dysfunction After Spinal Cord Injury. PM R. 2017.
45. Lemieux S, Despre´s JP, Moorjani S, Nadeau A, The´riault G, Prud’homme D, et al. Are gender differ-
ences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetolo-
gia. 1994; 37(8):757–64. PMID: 7988777
46. Lemieux S, Prud’homme D, Moorjani S, Tremblay A, Bouchard C, Lupien PJ, et al. Do elevated levels
of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concen-
trations in men? Atherosclerosis. 1995; 118(1):155–64. PMID: 8579625
47. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management
of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy:
a consensus statement of the American Diabetes Association and the European Association for the
Study of Diabetes. Diabetes Care. 2009; 32(1):193–203. https://doi.org/10.2337/dc08-9025 PMID:
18945920
48. Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, et al. Effect of diet and
exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal
women. Obesity (Silver Spring). 2012; 20(8):1628–38.
Anthropometrics cutoffs and spinal cord injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0203049 August 31, 2018 18 / 18
